Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blatter

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
The Pediatric Infectious Disease Journal|May 25, 2012
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of ageMark M Blatter, Nicola P Klein, Julie S Shepard, et al.
Pediatrics|August 3, 2001
Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate studyN Auestad, R Halter, R T Hall, et al.
Lancet (London, England)|November 16, 2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialDiane M Harper, Eduardo L Franco, Cosette Wheeler, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
The Journal of Infectious Diseases|November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccineS Frey, R Dagan, Y Ashur, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
The Pediatric Infectious Disease Journal|May 25, 2012
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of ageMark M Blatter, Nicola P Klein, Julie S Shepard, et al.
Pediatrics|August 3, 2001
Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate studyN Auestad, R Halter, R T Hall, et al.
Lancet (London, England)|November 16, 2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialDiane M Harper, Eduardo L Franco, Cosette Wheeler, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
The Journal of Infectious Diseases|November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccineS Frey, R Dagan, Y Ashur, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 13